Intravenous Lidocaine in Open Lung Resection Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

May 15, 2020

Study Completion Date

May 15, 2020

Conditions
LidocainePain, Postoperative
Interventions
DRUG

Lidocaine Iv

Patients in the Lidocaine group received a bolus of lidocaine 1% 1.5mg/kg at the induction of general anesthesia followed by a continuous infusion of lidocaine 1% 2mg/kg/h just before surgical incision and continued until 24h after the surgery

DRUG

Normal Saline

Patients in Group Placebo received an equal bolus volume of normal saline solution at induction, and then a continuous infusion started before surgical incision and maintained up until 24h postoperatively

Trial Locations (1)

1104 2020

Hotel Dieu de France, Beirut

All Listed Sponsors
lead

Saint-Joseph University

OTHER

NCT04480281 - Intravenous Lidocaine in Open Lung Resection Surgery | Biotech Hunter | Biotech Hunter